NexImmune (7370) Ratios
0 Followers
NexImmune Ratios
DE:7370's free cash flow for Q2 2024 was $-2.07M. For the 2024 fiscal year, DE:7370's free cash flow was increased by $2.00 and operating cash flow was $-2.07M. See a summary of the company’s cash flow.
| Ratios | Dec 23 | Dec 22 | Dec 21 | Mar 21 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.06 | 3.62 | 11.96 | 0.31 | 3.65 |
| Quick Ratio | 1.06 | 3.62 | 11.96 | 0.31 | 3.65 |
| Cash Ratio | 0.63 | 3.35 | 4.20 | 0.19 | 3.02 |
| Solvency Ratio | -6.16 | 47.93 | -7.00 | -1.15 | -6.39 |
| Operating Cash Flow Ratio | -6.18 | -4.95 | -6.35 | -0.98 | -6.42 |
| Short-Term Operating Cash Flow Coverage | -456.78 | 0.00 | 0.00 | -1.38 | 0.00 |
| Net Current Asset Value | $ 316.73K | $ 26.61M | $ 79.01M | $ -18.66M | $ 7.93M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.02 | 0.00 | 1.69 | 0.00 |
| Debt-to-Equity Ratio | 0.02 | 0.03 | 0.00 | -1.21 | 0.00 |
| Debt-to-Capital Ratio | 0.02 | 0.03 | 0.00 | 5.68 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.45 | 1.33 | 1.09 | -0.72 | 1.29 |
| Debt Service Coverage Ratio | -409.36 | 0.00 | -55.20 | -1.41 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | -58.82 | -16.55 | 0.00 |
| Debt to Market Cap | 0.03 | 0.00 | 0.00 | 0.03 | 0.00 |
| Interest Debt Per Share | 0.07 | 1.06 | 0.99 | 22.85 | 0.00 |
| Net Debt to EBITDA | 0.11 | 0.55 | 0.62 | -0.51 | 0.45 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | -822.61% | 101.66% | 105.94% | 98.80% |
| EBT Per EBIT | 110.80% | 99.09% | 95.58% | 107.23% | 98.38% |
| Return on Assets (ROA) | -376.36% | 1194.11% | -56.84% | -279.96% | -147.98% |
| Return on Equity (ROE) | -921.57% | 1591.88% | -61.78% | 200.83% | -191.31% |
| Return on Capital Employed (ROCE) | -831.76% | -192.76% | -63.54% | 177.11% | -195.32% |
| Return on Invested Capital (ROIC) | -800.38% | 1557.16% | -63.54% | -821.11% | -192.97% |
| Return on Tangible Assets | -376.36% | 1194.11% | -56.84% | -279.96% | -147.98% |
| Earnings Yield | -1388.28% | 8787.70% | -49.17% | -5.49% | -3.56% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.77 | 0.63 | 0.83 | 0.22 | 0.37 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -475.87 | -580.30 | -438.34 | -1627.57 | -980.04 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 475.87 | 580.30 | 438.34 | 1627.57 | 980.04 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -29.95 | -53.19 | -50.14 | -29.01 | -21.55 |
| Free Cash Flow Per Share | -30.00 | -54.50 | -52.71 | -29.96 | -22.94 |
| Dividend Paid and CapEx Coverage Ratio | -645.12 | -40.79 | -19.48 | -30.54 | -15.58 |
| Capital Expenditure Coverage Ratio | -645.12 | -40.79 | -19.48 | -30.54 | -15.58 |
| Operating Cash Flow Coverage Ratio | -456.78 | -49.95 | 0.00 | -1.38 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -1351.14% | -896.33% | -45.74% | -4.73% | -3.62% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.07 | 0.01 | -2.03 | -18.22 | -28.10 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.66 | 0.18 | 1.26 | -36.59 | 53.76 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.07 | -0.11 | -2.19 | -21.14 | -27.61 |
| Price-to-Operating Cash Flow Ratio | -0.07 | -0.11 | -2.30 | -21.83 | -29.38 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | -0.03 | -0.34 | -0.48 |
| Enterprise Value Multiple | 0.03 | 0.46 | -1.52 | -21.42 | -27.45 |
| Enterprise Value | -803.82K | -27.77M | 74.91M | 590.54M | 561.34M |
| EV to EBITDA | 0.03 | 0.46 | -1.52 | -21.42 | -27.45 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.03 | 0.53 | -1.56 | -21.66 | -27.17 |
| EV to Operating Cash Flow | 0.03 | 0.54 | -1.64 | -22.36 | -28.91 |
| Tangible Book Value Per Share | 3.34 | 33.56 | 91.73 | -17.31 | 11.78 |
| Shareholders’ Equity Per Share | 3.34 | 33.56 | 91.73 | -17.31 | 11.78 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 9.23 | -0.02 | -0.06 | 0.01 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -30.82 | 534.29 | -56.67 | -34.76 | -22.53 |
| Tax Burden | 1.00 | -8.23 | 1.02 | 1.06 | 0.99 |
| Interest Burden | 1.11 | 1.00 | 1.02 | 1.06 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.97 | 0.82 | 0.90 | 0.88 | 0.94 |
Currency in USD
